Senseonics (NYSE:SENS) Upgraded to "Strong-Buy" at Lake Street Capital

Senseonics (NYSE:SENS - Get Free Report) was upgraded by research analysts at Lake Street Capital to a "strong-buy" rating in a research report issued on Thursday,Zacks.com reports.

Several other brokerages have also weighed in on SENS. HC Wainwright reiterated a "buy" rating and issued a $1.40 price objective (up from $1.10) on shares of Senseonics in a research report on Tuesday, July 8th. Mizuho started coverage on Senseonics in a research report on Thursday, April 10th. They set an "outperform" rating and a $2.00 target price on the stock. Wall Street Zen raised Senseonics to a "sell" rating in a report on Monday, May 12th. Finally, TD Cowen began coverage on Senseonics in a report on Tuesday, July 15th. They set a "buy" rating and a $1.25 price target on the stock. One investment analyst has rated the stock with a sell rating, two have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Senseonics has an average rating of "Buy" and an average price target of $1.55.

Senseonics Stock Performance

Shares of SENS stock traded up $0.00 on Thursday, hitting $0.58. The company had a trading volume of 6,830,796 shares, compared to its average volume of 7,428,853. The firm has a market cap of $379.45 million, a P/E ratio of -4.46 and a beta of 0.92. The company has a 50-day moving average price of $0.52 and a 200-day moving average price of $0.68. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. Senseonics has a twelve month low of $0.25 and a twelve month high of $1.40.

Institutional Investors Weigh In On Senseonics

A number of large investors have recently bought and sold shares of the stock. First Light Asset Management LLC purchased a new position in Senseonics in the fourth quarter valued at about $3,366,000. Jane Street Group LLC increased its position in shares of Senseonics by 6,694.1% during the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company's stock worth $3,203,000 after acquiring an additional 6,028,726 shares during the last quarter. Renaissance Technologies LLC bought a new stake in Senseonics in the fourth quarter valued at about $720,000. Informed Momentum Co LLC bought a new stake in Senseonics in the first quarter valued at about $559,000. Finally, Millennium Management LLC increased its holdings in Senseonics by 299.0% in the fourth quarter. Millennium Management LLC now owns 1,088,029 shares of the company's stock valued at $569,000 after buying an additional 815,332 shares during the last quarter. Institutional investors and hedge funds own 12.36% of the company's stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.